Adjuvance Technologies Presents Data at the Annual Conference on Vaccinology Research (ACVR) Pre-clinical data on influenza and COVID-19 demonstrate benefits of TQL-1055 Lincoln, NE–April 28, 2021– Adjuvance Technologies Inc., a privately held biopharmaceutical company developing semi-synthetic saponin adjuvants and vaccines […]
Adjuvance Technologies Press Releases